Heart Failure with Preserved Ejection Fraction – Concept, Pathophysiology, Diagnosis and Challenges for Treatment

Authors

  • Lidija Veterovska Miljkovik Institute for Gerontology “13. November”, Skopje
  • Vera Spiroska University Clinic of Cardiology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje

DOI:

https://doi.org/10.3889/oamjms.2015.087

Keywords:

hearth failure, diastole, preserved ejection fraction, echocardiography, old people

Abstract

Heart failure (HF) with preserved left ventricular (LV) ejection fraction (HFpEF) occurs in 40 to 60% of the patients with HF, with a prognosis which is similar to HF with reduced ejection fraction (HFrEF). HFpEF pathophysiology is different from that of HFrEF, and has been characterized with diastolic dysfunction. Diastolic dysfunction has been defined with elevated left ventricular stiffness, prolonged iso-volumetric LV relaxation, slow LV filing and elevated LV end-diastolic pressure. Arterial hypertension occurs in majority cases with HFpEF worldwide. Patients are mostly older and obese. Diabetes mellitus and atrial fibrillation appear proportionally in a high frequency of patients with HFpEF. The HFpEF diagnosis is based on existence of symptoms and signs of heart failure, normal or approximately normal ejection and diagnosing of LV diastolic dysfunction by means of heart catheterization or Doppler echocardiography and/or elevated concentration of plasma natriuretic peptide. The present recommendations for HFpEF treatment include blood pressure control, heart chamber frequency control when atrial fibrillation exists, in some situations even coronary revascularization and an attempt for sinus rhythm reestablishment. Up to now, it is considered that no medication or a group of medications improve the survival of HFpEF patients. Due to these causes and the bad prognosis of the disorder, rigorous control is recommended of the previously mentioned precipitating factors for this disorder. This paper presents a universal review of the most important parameters which determine this disorder.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Rigolli M, Whalley GA. Heart failure with preserved ejection fraction. J Geriatr Cardiol. 2013;10(4):369-76.

Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, Hillege HL, van Veldhuisen DJ, van Gilst WH. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J. 2013;34(19):1424-31.

Asrar Ul, Haq M, Mutha V, Rudd N, Hare DL, Wong C. Heart failure with preserved ejection fraction - unwinding the diagnosis mystique. Am J Cardiovasc Dis. 2014;4(3):100-13.

Roscani MG, Matsubara LS, Matsubara BB. Heart failure with normal ejection fraction. Arq Bras Cardiol. 2010;94(5):652-60, 694-702.

Li SY, Du M, Dolence EK, Fang CX, Mayer GE, Ceylan-Isik AF, LaCour KH, Yang X, Wilbert CJ, Sreejayan N, Ren J. Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advanced glycation endproducts and protein modification. Aging Cell. 2005;4(2):57-64.

Phan TT, Shivu GN, Abozguia K, Sanderson JE, Frenneaux M. The pathophysiology of heart failure with preserved ejection fraction: from molecular mechanisms to exercise haemodynamics. Int J Cardiol. 2012;158(3):337-43.

Sachihiko N, Kengo S, Yukiko I, Hisanobu A, Masaaki S, Fumihiko M, Toshio N. Assessment of diastolic function in elderly patients with aortic stenosis. Evaluation of flow propagation velocity using color M-mode Doppler technique. Geriatric Gerontol Int. 2005; 5: 242-247.

Gerard AP, William GH. Diastolic heart failure. The New England J Medicine. 2004;351:1097-105.

El Aouar LM, Meyerfreud D, Magalhães P, Rodrigues SL, Baldo MP, Brasil Y, El Aouar SM, El Aouar NA, Mill JG, Campos Filho O. Relationship between left atrial volume and diastolic dysfunction in 500 Brazilian patients. Arq Bras Cardiol. 2013;101(1):52-8.

Zouein FA, de Castro Brás LE, da Costa DV, Lindsey ML, Kurdi M, Booz GW. Heart failure with preserved ejection fraction: emerging drug strategies. Journal of cardiovascular pharmacology. 2013; 62(1): 13.

Komamura K. Similarities and Differences between the Pathogenesis and Pathophysiology of Diastolic and Systolic Heart Failure. Cardiol Res Pract. 2013;2013:824135.

Ancona R, Comenale Pinto S, Caso P, D'Andrea A, Di Salvo G, Arenga F, Coppola MG, Sellitto V, Macrino M, Calabrò R. Left atrium by echocardiography in clinical practice: from conventional methods to new echocardiographic techniques. ScientificWorldJournal. 2014;2014:451042.

Fontes-Carvalho R, Leite-Moreira A. Heart failure with preserved ejection fraction: fighting misconceptions for a new approach. Arq Bras Cardiol. 2011;96(6):504-14.

Asrar ul Haq M, Wong C, Mutha V, Anavekar N, Lim K, Barlis P, Hare DL. Therapeutic interventions for heart failure with preserved ejection fraction: A summary of current evidence. World J Cardiol. 2014;6(2):67-76.

Soma J. Heart failure with preserved left ventricular ejection fraction: concepts, misconceptions and future directions. Blood Press. 2011;20(3):129-33.

Kumar A, Meyerrose G, Sood V, Roongsritong C. Diastolic heart failure in the elderly and the potential role of aldosterone antagonists. Drugs Aging. 2006;23(4):299-308.

Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28(20):2539-50.

Todaro MC, Choudhuri I, Belohlavek M, Jahangir A, Carerj S, Oreto L, Khandheria BK. New echocardiographic techniques for evaluation of left atrial mechanics. Eur Heart J Cardiovasc Imaging. 2012;13(12):973-84.

Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, Duvinage A, Stahrenberg R, Durstewitz K, Löffler M, Düngen HD, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Pieske B; Aldo-DHF Investigators. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA. 2013;309(8):781-91.

Dénes M, Kiss I, Lengyel M. Assessment of diastolic dysfunction in elderly hypertensive patients using integrated Doppler echocardiography. Blood Press. 2009;18(3):135-41.

Russo C, Jin Z, Homma S, Rundek T, Elkind MS, Sacco RL, Di Tullio MR. Left atrial minimum volume and reservoir function as correlates of left ventricular diastolic function: impact of left ventricular systolic function. Heart. 2012;98(10):813-20.

Velagaleti RS, Gona P, Pencina MJ, Aragam J, Wang TJ, Levy D, D'Agostino RB, Lee DS, Kannel WB, Benjamin EJ, Vasan RS. Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction. Am J Cardiol. 2014;113(1):117-22.

Popescu BA, Popescu AC, Antonini-Canterin F, Rubin D, Cappelletti P, Piazza R, Ginghina C, Dimulescu D, Beladan CC, Nicolosi GL. Prognostic role of left atrial volume in elderly patients with symptomatic stable chronic heart failure: comparison with left ventricular diastolic dysfunction and B-type natriuretic peptide. Echocardiography. 2007;24(10):1035-43.

Yamamoto K, Origasa H, Hori M; J-DHF Investigators. Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF). Eur J Heart Fail. 2013;15(1):110-8.

Lalande S, Johnson BD. Diastolic dysfunction: a link between hypertension and heart failure. Drugs Today (Barc). 2008;44(7):503-13.

Russo C, Jin Z, Homma S, Rundek T, Elkind MS, Sacco RL, Di Tullio MR. Left atrial minimum volume and reservoir function as correlates of left ventricular diastolic function: impact of left ventricular systolic function. Heart. 2012;98(10):813-20.

Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, Duvinage A, Stahrenberg R, Durstewitz K, Löffler M, Düngen HD, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Pieske B; Aldo-DHF Investigators. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA. 2013;309(8):781-91.

Published

2015-07-28

How to Cite

1.
Veterovska Miljkovik L, Spiroska V. Heart Failure with Preserved Ejection Fraction – Concept, Pathophysiology, Diagnosis and Challenges for Treatment. Open Access Maced J Med Sci [Internet]. 2015 Jul. 28 [cited 2022 Aug. 14];3(3):521-7. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2015.087

Issue

Section

F - Review Articles